Gynecological Cancer: Approach to Care

Gynecologic Oncology is one of four divisions in the Department of Obstetrics and Gynecology at the University of Florida College of Medicine. Our physicians specialize in the treatment of patients with gynecologic cancers including cancers of the uterus, cervix, vagina, ovary, Fallopian tube, vulva and gestational trophoblastic disease. Our physicians specialize in all aspects of gynecologic cancer and offer the latest diagnostic techniques, innovative treatment options and gynecologic reconstructive surgery.

Multidisciplinary Treatment Team

Our multidisciplinary treatment team includes physicians, nurses and staff who are experts in gynecologic cancer. The exchange of knowledge and opinions among team members means that patients benefit from the combined expertise of multiple cancer specialists from many disciplines who carefully review patient information and develop the best possible treatment plan for each individual. Our patients benefit from numerous services including:

  • Integrated clinical experience
  • Surgical oncology
  • Medical oncology
  • Radiation oncology
  • Clinical trials
  • Pathology
  • Radiology
  • Psychosocial support
  • Fertility Preservation
  • Genetic counseling
  • Patient educators and resources
  • Personal wellness and rehabilitation programs
  • Palliative care
  • Prevention and screening

Comprehensive Patient Care

For many years the Department of Obstetrics and Gynecology has been ranked by the US News and World Report as one of the top 50 ObGyn departments in the nation. This is just one reflection of our high standard of patient care, teaching and research. With over 50,000 patient visits a year in our clinics, almost 3,000 deliveries a year, gynecologic surgery, oncology and infertility services, we are a very busy and highly successful department. Even with such a busy clinical service, we have been able to maintain a highly personalized approach to each patient and were recently awarded a five star award for patient satisfaction.

The Division of Gynecologic Oncology’s predominant area of research has been clinical with emphasis on the management of ovarian malignancies with radioactive phosphorus, also known as P-32, and various chemotherapeutic trials in ovarian and cervical cancer. This active research program puts us in a unique position to offer patients the latest innovative technology and state-of-the-art treatment options, including:

  • Minimally invasive surgery
  • Traditional surgery
  • Reconstructive surgery
  • Chemotherapy
  • Radiation therapy
  • Fertility preservation